Table 2. Propensity score matching data description.
| Parameters | Total population |
Propensity-matched population |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Non-NT (n=122) | NT (n=70) | P value | Standardized difference | Non-NT (n=70) | NT (n=70) | P value | Standardized difference | ||
| Age | 63.9±9.1 | 63.9±9.9 | 0.991 | −0.002 | 64.0±8.5 | 63.9±9.9 | 0.934 | −0.013 | |
| Male | 110 (90.2%) | 68 (97.1%) | 0.088 | −0.416 | 68 (97.1%) | 68 (97.1%) | 1.000 | 0.000 | |
| Tumor SUVmax | 7.1±5.6 | 6.0±4.0 | 0.115 | −0.277 | 6.2±5.0 | 6.0±4.0 | 0.820 | −0.044 | |
| LN SUVmax | 2.9±2.1 | 3.1±2.6 | 0.508 | 0.088 | 3.2±2.2 | 3.1±2.6 | 0.911 | −0.017 | |
NT, neoadjuvant therapy; SUVmax, maximum standard uptake values; LN, lymph nodes.